- Home
- GHG vs GOSS Comparison
GHG vs GOSS Comparison
Compare GHG & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHG
- GOSS
- Stock Information
- Founded
- GHG 2004
- GOSS 2015
- Country
- GHG China
- GOSS United States
- Employees
- GHG N/A
- GOSS N/A
- Industry
- GHG Hotels/Resorts
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- GHG Consumer Discretionary
- GOSS Health Care
- Exchange
- GHG Nasdaq
- GOSS Nasdaq
- Market Cap
- GHG 259.8M
- GOSS 212.9M
- IPO Year
- GHG 2018
- GOSS 2019
- Fundamental
- Price
- GHG $2.43
- GOSS $0.83
- Analyst Decision
- GHG
- GOSS Strong Buy
- Analyst Count
- GHG 0
- GOSS 5
- Target Price
- GHG N/A
- GOSS $9.20
- AVG Volume (30 Days)
- GHG 13.3K
- GOSS 2.1M
- Earning Date
- GHG 02-25-2025
- GOSS 11-07-2024
- Dividend Yield
- GHG 3.97%
- GOSS N/A
- EPS Growth
- GHG N/A
- GOSS N/A
- EPS
- GHG 0.28
- GOSS N/A
- Revenue
- GHG $201,166,731.00
- GOSS $105,322,000.00
- Revenue This Year
- GHG N/A
- GOSS N/A
- Revenue Next Year
- GHG $8.78
- GOSS N/A
- P/E Ratio
- GHG $9.06
- GOSS N/A
- Revenue Growth
- GHG N/A
- GOSS N/A
- 52 Week Low
- GHG $2.31
- GOSS $0.50
- 52 Week High
- GHG $3.85
- GOSS $1.60
- Technical
- Relative Strength Index (RSI)
- GHG 42.97
- GOSS 52.12
- Support Level
- GHG $2.40
- GOSS $0.76
- Resistance Level
- GHG $2.71
- GOSS $0.87
- Average True Range (ATR)
- GHG 0.10
- GOSS 0.09
- MACD
- GHG -0.00
- GOSS 0.01
- Stochastic Oscillator
- GHG 31.71
- GOSS 31.23
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.